Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBWECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBWECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBWEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBWEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.3.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAY.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAY.1.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.1.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GY.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GY.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.61 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.61 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.61 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.61 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used